Edward Schutter

Directeur/Membre du Conseil chez ESTABLISHMENT LABS HOLDINGS INC. Fortune : 14 M $ au 31/05/2026

Profil

Edward J.
Schutter is the founder of Ventrus Biosciences, Inc., Arbor Pharmaceuticals LLC.
Current positions include Chief Executive Officer at NitroMed, Inc., Director at Tidal Vision Products, Inc., Director at Vitruvias Therapeutics, Inc. since 2018, Director at Establishment Labs SA since 2016, Executive Director & Founding Member at Bio, Independent Non-Executive Director at Establishment Labs Holdings, Inc. since 2015, Independent Director at Terrascend Corp.
since 2020, and Director at Intrance Medical Systems, Inc. since 2022.
Former roles include President & Chief Executive Officer at Arbor Pharmaceuticals, Inc. from 2010 to 2021, Chairman at Center for Global Health Innovation, Inc., Director at Vensun Pharmaceuticals, Inc., Director at Knight Therapeutics, Inc., Director at Mercer University, Managing Director at XenoPort, Inc., Director at American Diabetes Association, Vice President-Global Business Development at Solvay SA from 2002 to 2006, President & Chief Operating Officer at Shionogi Pharma, Inc. from 2007 to 2009, Vice President-Global Business Development at Solvay Pharmaceuticals, Inc. from 1990 to 2005, Trustee at American Heart Association, Inc., Vice President-Global Business Development at Abbott Products Operations AG, and President at Sciele Pharmaceuticals, Inc. from 2006 to 2009.
Education includes undergraduate studies at Mercer University, an MBA from Kennesaw State University, and graduate studies at Nyenrode Business Universiteit.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ESTABLISHMENT LABS HOLDINGS, INC. 0,61 %	22/05/2026	177 736 ( 0,61 % )	13 M $	31/05/2026
TERRASCEND CORP. 0,79 %	13/04/2026	2 451 337 ( 0,79 % )	2 M $	31/05/2026

Postes actifs de Edward Schutter

Sociétés	Poste	Début
ESTABLISHMENT LABS HOLDINGS INC.	Directeur/Membre du Conseil	01/08/2015
TERRASCEND CORP.	Directeur/Membre du Conseil	02/11/2020
Intrance Medical Systems, Inc.	Directeur/Membre du Conseil	04/01/2022
NitroMed, Inc.	Directeur Général	-
Vitruvias Therapeutics, Inc.	Directeur/Membre du Conseil	10/01/2018
Bio/Med Investor Network	Directeur/Membre du Conseil	-
Establishment Labs SA	Directeur/Membre du Conseil	01/01/2016
Tidal Vision Products, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Edward Schutter

Sociétés	Poste	Fin
Arbor Pharmaceuticals, Inc.	Directeur Général	01/01/2021
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░	░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░